Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXA58Y
|
||||
| Drug Name |
(S)-benzyl 1-(2-(4-methoxyphenylamino)ethylamino)-4-methyl-1-oxopentan-2-ylcarbamate
|
||||
| Synonyms |
CHEMBL60242
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H31N3O4
|
||||
| Canonical SMILES |
COc1ccc(NCCNC(=O)[C@H](CC(C)C)NC(=O)OCc2ccccc2)cc1
|
||||
| InChI |
InChI=1S/C23H31N3O4/c1-17(2)15-21(26-23(28)30-16-18-7-5-4-6-8-18)22(27)25-14-13-24-19-9-11-20(29-3)12-10-19/h4-12,17,21,24H,13-16H2,1-3H3,(H,25,27)(H,26,28)/t21-/m0/s1
|
||||
| InChIKey |
FABDEVCIFFZYAX-NRFANRHFSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.